We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Guangzhou Pluslife Biotech Co., Ltd.

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Macadamia Nut-Specific IgE Levels Predict Anaphylaxis

By LabMedica International staff writers
Posted on 24 Oct 2022
Print article
Image: Macadamia Nut-Specific IgE Levels Predict Anaphylaxis (Photo courtesy of Healthians)
Image: Macadamia Nut-Specific IgE Levels Predict Anaphylaxis (Photo courtesy of Healthians)

Proteins residing in tree nuts are mistakenly treated as harmful by the immune system, which then releases antibodies to combat them. Chemical reaction triggers within protein substances, mast cells and histamines produced by immune system resulting in allergic symptoms.

Tree nut allergy symptoms typically occur within minutes of ingestion and can range from hives to anaphylaxis, a potentially life-threatening reaction that impairs breathing and can send the body into shock. In terms of prevalence, less than 5% of people in the USA who are sensitized to tree nuts are allergic to macadamia nuts.

Allergists and immunologists from the Sagamihara National Hospital (Sagamihara, Japan) included in a study 41 children (71% boys; median age, 7.7 years) with suspected macadamia nut allergy who visited the hospital between April 2012 and July 2021. Patient interviews and a three-level stepwise oral food challenge (OFC) found that 21 of these children had an allergy and 20 did not. The study aimed to investigate macadamia nut-specific immunoglobulin E (Md-sIgE).

Eight of the allergic children (38%) had experienced anaphylaxis. Symptoms included generalized urticaria, cough, wheezing, throat pruritus, abdominal pain, lip swelling and recurrent emesis. Among the other 13 allergic children (62%) who did not experience anaphylaxis, symptoms included face swelling, localized or generalized urticaria, intermittent cough, lip swelling and throat pruritus. None of the allergic children experienced mild subjective symptoms that were localized to the oral cavity.

The investigators collected blood samples from all patients within 12 months of the OFC or the allergic reaction to macadamia nut. The median level of macadamia nut-specific IgE (Md-sIgE) for the full cohort was 2.23 kUA/L. The children with allergy and anaphylaxis had higher Md-sIgE levels (median, 7.97 kUA/L; interquartile range [IQR], 5.08-23.3) than the children with allergy who did not have anaphylaxis (median, 1.92 kUA/L; IQR, 0.83-6.04) and those who did not have allergy (median, 1.9 kUA/L; IQR, 0.56-2.78). The difference between the latter two groups did not reach significance.

Based on receiver operating characteristic analysis for predicting anaphylaxis using Md-sIgE levels, the researchers found that the area under the curve of Md-sIgE was 0.92 (95% CI, 0.83-1) with an optimal cutoff value of 3.76 kUA/L. Eight of the 16 children (50%) with Md-sIgE levels over this level and none of the children with levels under that benchmark developed anaphylaxis.

Also, positive predictive values for anaphylaxis included 5% for 1.8 kUA/L, 10% for 2.75 kUA/L, 20% for 4.36 kUA/L, 80% for 21.06 kUA/L, 90% for 33.38 kUA/L and 95% for 51.04 kUA/L, with a maximum value of 38.3 kUA/L. About one-third of the children with sIgE values under 3.76 kUA/L had a macadamia nut allergy with no anaphylaxis, indicating that OFC could be safe for them.

The authors concluded that Md-sIgE levels were useful in predicting anaphylaxis. Above the cut-off value, they emphasized paying careful attention to the risk of anaphylaxis. The study was first published on September 18, 2022 in the journal Pediatric Allergy and Immunology.

Related Links:
Sagamihara National Hospital

Gold Supplier
Infectious Diseases Controls
Multichem ID-SeroNeg
Molecular Diagnostic STI Test
Clinical Centrifuge
Antimicrobial Susceptibility Test (AST)

Print article


Clinical Chem.

view channel
Image: Equivalence of Genetically Elevated LDL and Lipoprotein(a) on Myocardial Infarction (Photo courtesy of Viborg Regional Hospital)

Familial Hypercholesterolemia Patients With ACD Have Elevated Lipoprotein(a)

Familial hypercholesterolemia (FH) is a genetic disorder characterized by high cholesterol levels, specifically very high levels of low-density lipoprotein (LDL cholesterol), in the blood and early cardiovascular... Read more

Molecular Diagnostics

view channel
Image: A cheap blood test could improve diagnosis of myocarditis (Photo courtesy of Queen Mary University of London)

First-Ever Blood Test Could Detect Deadly Heart Inflammation Within Hours

Myocarditis, or inflammation of the heart muscle, is a difficult condition to diagnose. Symptoms include a temperature, fatigue, chest pain and shortness of breath, which can all be easily mistaken for... Read more


view channel
Image: Ring-form trophozoites of Plasmodium vivax in a thin blood smear (Photo courtesy of Centers for Disease Control and Prevention)

Immune Regulators Predict Severity of Plasmodium vivax Malaria

Cytokines and chemokines are immune response molecules that display diverse functions, such as inflammation and immune regulation. In Plasmodium vivax infections, the uncontrolled production of these molecules... Read more


view channel
Image: Breast cancer spread uncovered by new molecular microscopy (Photo courtesy of Wellcome Sanger Institute)

New Molecular Microscopy Tool Uncovers Breast Cancer Spread

Breast cancer commonly starts when cells start to grow uncontrollably, often due to mutations in the cells. Overtime the tumor becomes a patchwork of cells, called cancer clones, each with different mutations.... Read more


view channel
Image: With Cell IDx’s acquisition, Leica Biosystems will be moving its multiplexing menu forward (Photo courtesy of Leica Biosystems)

Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling

Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.